FRA:SBX • DE000A3E5A59
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SYNBIOTIC SE (SBX.DE).
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.45M | 8.649M 58.69% | 20.2M 133.56% | 5.526M -72.64% | 16.249M 194.05% | 16.564M 1.94% | 19.241M 16.16% | 23.887M 24.15% | N/A | ||
| EBITDA YoY % growth | N/A | -710K | 2.796M 493.76% | -404K -114.45% | -2.625M -549.75% | -1.768M 32.67% | -1.465M 17.14% | 50.5K 103.45% | 1.111M 2,100.00% | 2.639M 137.53% | |
| EBIT YoY % growth | -10K | -830K -8,200.00% | -5.52M -565.00% | -1.515M 72.55% | -5.932M -291.53% | -2.479M 58.21% | -2.273M 8.33% | -808K 64.44% | 353.5K 143.75% | N/A | |
| Operating Margin | N/A | -15.23% | -63.82% | -7.50% | -107.34% | -15.26% | -13.72% | -4.20% | 1.48% | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.19 79.67% | -0.58 -207.80% | -0.33 43.87% | -0.36 -9.23% | -0.15 59.15% | 0.01 103.45% | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
6 analysts have analysed SBX.DE and the average price target is 6.17 EUR. This implies a price increase of 173.66% is expected in the next year compared to the current price of 2.255.
The number of analysts covering SYNBIOTIC SE (SBX.DE) is 6.